Regulatory Affairs and Compliance

Navigating the Future

The regulatory revolution in gene therapy

The cell and gene therapies CGTs landscape is evolving rapidly with transformative potential to potentially cure

Why Early CMC Strategy Matters for Asian Biotech

In July the FDA published Complete Response letters CRLs offering significant transparency

The JAPAC Drug Development Market

Understanding the regulatory landscape and cultural nuances

Regulatory authorities are critical to the development and commercialisation of drugs as they govern the safety

CELL AND GENE THERAPY (CGT)

Key regulatory insights

CGT stands at the forefront of personalised medicine revolutionising healthcare by modifying patients

Unveiling the Evolution

A thought leader's insights into the pharmacovigilance industry

Getting exposure very early on in the science and business of pharmacovigilance was a very fortunate thing for me

UNIFYING DRUG SAFETY

The significance of harmonisation in pharmacovigilance

In pharmacovigilance harmonisation refers to the collaborative effort among regulatory authorities

Nitrosamine Control and Prevention

A comprehensive approach

Nitrosamine describes a class of compounds with a nitroso groups chemical structure bonded to an amine

An introduction to FDA’s Human Factors Engineering Requirements for Drug-Device Combination Products

Although less well known than other drug development phases human factors engineering HFE is critical to meeting regulatory expectations for drugdevice combination products

Technological and Regulatory Changes in Pharmacovigilance

Oracle’s safety management systems

Maintaining regulatory compliance in a global marketplace is increasingly challenging as wellestablished regulators and regional local regulators increase their digital capabilities and expectations of Marketing Authorization Holders MAHs

What Are The 5 Factors You Need to Ensure GMP Compliance?

Video and Article:

This webinar aims to help you understand five critical factors in helping you sustain your GMP compliance It also aims to help you understand the criticality of those factors FDA Inspection Issues Firstly if one were to look at the last three years data on the FDA website and look at the issues